ACRRM MCQ

Practice session

A 55-year-old Aboriginal man with type 2 diabetes has an HbA1c of 9.2% despite maximal metformin. He has an eGFR of 70 mL/min/1.73m2 and established cardiovascular disease. Which add-on agent best addresses both glycaemic control and his cardiovascular risk?

Loading your practice session…